|

Celecoxib Clinical Trials

12 actively recruiting trials across 3 locations

Also known as: , Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-,, Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-, Cele, Celebrex, Celebrex, Celecoxib, CELECOXIB, CELECOXIB, 169590-42-5, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide +7 more

Pipeline

Early 1: 1Phase 2: 7Phase 3: 2Phase 4: 1

Top Sponsors

  • Fudan University2
  • Emory University2
  • Zhejiang University1
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1
  • Universiteit Antwerpen1

Indications

  • Cancer8
  • Arthritis3
  • Knee Osteoarthritis2
  • Rare CNS Tumor Recurrent1
  • Hip Osteoarthritis1

Other7 trials

99Tc-MDP Treatment for Knee Osteoarthritis
N/A
Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Phase 3
INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder
Phase 3
Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)
Phase 2
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
Phase 2
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Early 1
Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
Phase 2

Atlanta, Georgia2 trials

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

Grady Health System

Phase 2
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Aflac Cancer & Blood Disorders Centers

Phase 2

Chicago, Illinois2 trials

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Ann & Robert H. Lurie Children's Hospital of Chicago

Phase 2
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Northwestern University

Phase 4

Rochester, Minnesota1 trial

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population

Mayo Clinic in Rochester

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.